KDR and neoplasm: Dual blocking of ANGPT2 and VEGFR2 effectively impaired glioma progression, promoted vascular normalization, blocked macrophage recruitment, and prolongered the prognosis of tumor-bearing mouse models (Kloepper et al., 2016; Peterson et al., 2016).